Literature DB >> 7600096

Physiological effects produced by botulinum toxin treatment of upper limb dystonia. Changes in reciprocal inhibition between forearm muscles.

A Priori1, A Berardelli, B Mercuri, M Manfredi.   

Abstract

Patients with upper limb dystonia have abnormal reciprocal inhibition between flexor and extensor forearm muscles. To see whether botulinum toxin treatment alters segmental motor system function, we studied reciprocal inhibition between forearm flexor and extensor muscles, before and after botulinum toxin injection in forearm muscles in 12 patients with upper limb dystonia. Reciprocal inhibition was studied by conditioning the H reflex in forearm flexors with a radial nerve stimulus delivered at a range of time intervals. Botulinum toxin injection improved upper limb dystonia. Before botulinum toxin injection, the dystonic patients had a decreased second phase of reciprocal inhibition. After botulinum toxin injections this second abnormal phase of reciprocal inhibition increased. Botulinum toxin did not change the first phase of reciprocal inhibition. Botulinum toxin treatment also reduced the M wave and the H reflex by a similar amount but left the Hmax:Mmax ratio unchanged. Ample evidence has shown that the therapeutic effects of botulinum toxin in dystonia depend mainly on its neuromuscular junction blocking action. Our data now suggest a concurrent indirect effect on spinal cord circuitry, probably through the action of botulinum toxin on the intrafusal neuromuscular junction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7600096     DOI: 10.1093/brain/118.3.801

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  35 in total

Review 1.  Uses of botulinum toxin injection in medicine today.

Authors:  A Münchau; K P Bhatia
Journal:  BMJ       Date:  2000-01-15

2.  Excitability of the human trigeminal motoneuronal pool and interactions with other brainstem reflex pathways.

Authors:  G Cruccu; A Truini; A Priori
Journal:  J Physiol       Date:  2001-03-01       Impact factor: 5.182

Review 3.  Convergent mechanisms in etiologically-diverse dystonias.

Authors:  Valerie B Thompson; H A Jinnah; Ellen J Hess
Journal:  Expert Opin Ther Targets       Date:  2011-12-03       Impact factor: 6.902

Review 4.  Neurophysiological effects of botulinum toxin type A.

Authors:  G Abbruzzese; A Berardelli
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

Review 5.  Botulinum toxin for pain.

Authors:  Roberto Casale; Valeria Tugnoli
Journal:  Drugs R D       Date:  2008

Review 6.  Treatment and physiology in Parkinson's disease and dystonia: using transcranial magnetic stimulation to uncover the mechanisms of action.

Authors:  Aparna Wagle Shukla; David E Vaillancourt
Journal:  Curr Neurol Neurosci Rep       Date:  2014-06       Impact factor: 5.081

7.  Effects of botulinum toxin type A on vibration induced facilitation of motor evoked potentials in spasmodic torticollis.

Authors:  P P Urban; R Rolke
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-11       Impact factor: 10.154

Review 8.  Task-specific dystonias: a review.

Authors:  Diego Torres-Russotto; Joel S Perlmutter
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

Review 9.  Botulinum toxin therapy for myofascial pain disorders.

Authors:  Amy M Lang
Journal:  Curr Pain Headache Rep       Date:  2002-10

10.  Botulinum toxin.

Authors:  P K Nigam; Anjana Nigam
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.